Ana Isabel Pérez Zapata

Statistics

Publications

Citations

137

H-Index

Active since

2015

Affiliations

National University Heart Centre Singapore(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

National Heart Centre Singapore

Bayer (Germany)

Clinical Research Institute

Ana Isabel Pérez Zapata is an author at National University Heart Centre Singapore specializing in heart failure pharmacotherapy, medicine, and preoperative risk assessment.

ORCID

Publications per year

2015–2025

Publications

Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event

Carolyn S.P. Lam, Anna Giczewska, Karen Sliwa et al. · JAMA Cardiology · 2020 · 82 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 32 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Detection of Adverse Events in General Surgery Using the “Trigger Tool” Methodology

Ana Isabel Pérez Zapata, María Gutiérrez Samaniego, Elías Rodríguez Cuéllar et al. · Cirugía Española (English Edition) · 2015 · 23 citations

Medicine, Perioperative Medicine, Surgery +16

1–3 of 3